Literature DB >> 1576069

Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects.

A P Sampson1, R U Thomas, J F Costello, P J Piper.   

Abstract

1. We have investigated the capacities of peripheral leukocytes from atopic asthmatic (AA) (n = 7), atopic non-asthmatic (AN) (n = 7), and normal (N) (n = 7) subjects to generate the bronchoconstrictor and proinflammatory mediators leukotrienes (LTs) B4 and C4. 2. Mixed leukocyte preparations containing 61-84% neutrophils, 2.4-15% eosinophils, and 13-29% mononuclear cells were incubated in vitro at 37 degrees C in the presence of calcium ionophore A23187. Synthesis of LTB4 and LTC4 was quantitated by radioimmunoassay. 3. Both in dose-response experiments (0-10 microM A23187 for 5 min), and in time-course investigations (2 microM A23187 for 0-30 min), the mixed leukocytes of the AA and AN subjects generated on average 4- to 5-fold more LTB4 and 3- to 5-fold more LTC4 than the normal leukocytes (P less than 0.01 in all cases; ANOVA). 4. This enhanced LT synthesis by the AN and AA leukocytes was not due to differences in the counts of leukocyte sub-types, or to altered rates of LT catabolism between the subject groups. 5. LTB4 synthesis correlated significantly with LTC4 synthesis in the leukocytes of the AN and AA subjects (r = 0.81, n = 14, P less than 0.01), but not in those of the normal subjects (r = 0.19, n = 7, P greater than 0.05). 6. Our results demonstrate an up-regulation of the leukotriene synthetic pathway in the circulating leukocytes of atopic non-asthmatic and atopic asthmatic subjects, which may have important implications in the pathophysiology of asthma and allergy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576069      PMCID: PMC1381333          DOI: 10.1111/j.1365-2125.1992.tb04062.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  33 in total

1.  Characterization of the neutrophil respiratory burst in atopy.

Authors:  B Styrt; R E Rocklin; M S Klempner
Journal:  J Allergy Clin Immunol       Date:  1988-01       Impact factor: 10.793

2.  Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects.

Authors:  I K Taylor; K M O'Shaughnessy; R W Fuller; C T Dollery
Journal:  Lancet       Date:  1991-03-23       Impact factor: 79.321

3.  Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.

Authors:  P J Manning; R M Watson; D J Margolskee; V C Williams; J I Schwartz; P M O'Byrne
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

4.  The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air.

Authors:  E Israel; R Dermarkarian; M Rosenberg; R Sperling; G Taylor; P Rubin; J M Drazen
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

5.  Synthesis and release of leukotriene C4 by human eosinophils.

Authors:  W F Owen; R J Soberman; T Yoshimoto; A L Sheffer; R A Lewis; K F Austen
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

6.  Novel transcellular interaction: conversion of granulocyte-derived leukotriene A4 to cysteinyl-containing leukotrienes by human platelets.

Authors:  C Edenius; K Heidvall; J A Lindgren
Journal:  Eur J Biochem       Date:  1988-12-01

7.  The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects.

Authors:  J P Arm; B W Spur; T H Lee
Journal:  J Allergy Clin Immunol       Date:  1988-10       Impact factor: 10.793

8.  Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects.

Authors:  N C Barnes; P J Piper; J F Costello
Journal:  Thorax       Date:  1984-07       Impact factor: 9.139

9.  Human granulocyte-macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis.

Authors:  J F DiPersio; P Billing; R Williams; J C Gasson
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

10.  Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals.

Authors:  C A Dahinden; J Zingg; F E Maly; A L de Weck
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  8 in total

1.  Priming effect of platelet activating factor on leukotriene C4 from stimulated eosinophils of asthmatic patients.

Authors:  K Shindo; K Koide; Y Hirai; M Sumitomo; M Fukumura
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

2.  Leukotriene A4 hydrolase in peripheral leukocytes of patients with atopic dermatitis.

Authors:  H Okano-Mitani; K Ikai; S Imamura
Journal:  Arch Dermatol Res       Date:  1996-04       Impact factor: 3.017

3.  Effect of intravenous corticosteroid on ex vivo leukotriene generation by blood leucocytes of normal and asthmatic patients.

Authors:  P P Hood; T P Cotter; J F Costello; A P Sampson
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

4.  Eicosanoid mediator expression in mononuclear and polymorphonuclear cells in normal subjects and patients with atopic asthma and cystic fibrosis.

Authors:  L M Kuitert; R Newton; N C Barnes; I M Adcock; P J Barnes
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

Review 5.  Leukotrienes as a target in asthma therapy.

Authors:  N Chanarin; S L Johnston
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

6.  Persistent increase in plasma and urinary leukotrienes after acute asthma.

Authors:  A P Sampson; D P Castling; C P Green; J F Price
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

7.  5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors.

Authors:  C Chavis; I Vachier; P Chanez; J Bousquet; P Godard
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

Review 8.  Cysteinyl leukotrienes and their receptors; emerging concepts.

Authors:  Yoshihide Kanaoka; Joshua A Boyce
Journal:  Allergy Asthma Immunol Res       Date:  2014-05-27       Impact factor: 5.764

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.